USFDA nod to physiotherapy monitoring device Pheezee

The device generates reports, for the first time in the field of physiotherapy, enabling patients to track their recovery.

Published On 2023-05-03 11:00 GMT   |   Update On 2023-05-03 11:01 GMT
Advertisement

Hyderabad: Startoon Labs Private Limited, a Hyderabad-based medical device R&D, Engineering and Manufacturing Company has announced it has received US FDA (The US Food and Drug Administration) (510 K Exempt) clearance for its revolutionary physiotherapy monitoring device ‘ Pheezee’, the first of kind in the world.

Pheezee is certified for electrical and environmental safety as per international standards and is a registered medical device with the Central Drugs Standard Control Organization (CDSCO) and the device is a game-changer in the field of physiotherapy and rehabilitation, Startoon Labs, one of the most vibrant startups among 4,000 startups in Telangana, said in a release here.
Advertisement
Pheezee is a patented technology, capable of measuring the surface Electromyogram (sEMG) of bulk muscles and Range of motion (ROM) of primary joints simultaneously, to determine joint health, making it a one-of-a-kind product in the world with this capability, said Suresh Susurla, Founder & CEO, Startoon Labs.
The device is helpful in assessing joint health during physiotherapy post musculoskeletal, neurological, spinal cord injuries and neuro-ailments such as paralysis, hemiplegia, paraplegia, muscular dystrophy, he claimed.
It generates reports, for the first time in the field of physiotherapy, enabling patients to track their recovery.
Pheezee, being an IOT-enabled device, enables telerehabilitation of the patients and allows them to continue doing physiotherapy sessions at home and still keep the referring surgeon updated about the progress, he said.
It is a revolutionary device set to transform the way assessments, monitoring and tracking of recovery is done in the field of physiotherapy, says Mythreyi Kondapi Co-founder of the medical technology startup.
The flagship product of the company already enjoys national and international recognition and with USFDA’s nod, its reach is going to be widened even further. Now it will demonstrate its performance in the USA and many other global markets, he said.
It is a proud moment not just for us, but for the entire MedTech startup community in the state that Pheezee is now a globally accepted Made in Telangana product, Suresh, a well-acclaimed professional who has 11 international publications to his credit (co-authored), said.
As a part of the rapidly growing MedTech industry in India, valued at $10.86 billion in 2020, Startoon Labs is at the forefront of the digital technology segment. The sector is poised for growth, at a CAGR of 37 percent and to reach $50 billion by 2025, he added.

Read also: Boehringer Ingelheim Spesolimab bags USFDA Breakthrough Therapy Designation for prevention of generalized pustular psoriasis flares

Tags:    
Article Source : UNI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News